Expression and molecular profiles of the AlkB family in ovarian serous carcinoma

被引:3
|
作者
Cai, Yuan [1 ]
Wu, Geting [1 ]
Peng, Bi [1 ]
Li, Juanni [1 ]
Zeng, Shuangshuang [2 ]
Yan, Yuanliang [2 ]
Xu, Zhijie [1 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha 410008, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha 410008, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha 410008, Hunan, Peoples R China
来源
AGING-US | 2021年 / 13卷 / 07期
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
ovarian serous carcinoma; AlkB family; expression profiles; infiltrating immune cells; methylation; CANCER PROGRESSION; M(6)A;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
AlkB family of Fe (II) and alpha-ketoglutarate-dependent dioxygenases plays essential roles in development of ovarian serous carcinoma (OV). However, the molecular profiles of AlkB family in OV have not been clarified. The results indicated that the expression of ALKBH1/3/5/8 and FTO was lower in OV patients while ALKBH2/4/6/7 expression was higher. There was a strong correlation between ALKBH5/7 and pathological stage of OV patients. KaplanMeier plotter revealed that OV patients with high ALKBH4 level showed longer overall survival (OS). However, patients with high levels of ALKBH5/6 and FTO showed shorter OS and progression-free survival (PFS). Genetic alterations using cBioPortal revealed that the alteration rates of FTO were the highest. We also found that the functions of AlkB family were linked to several cancer-associated signaling pathways, including chemokine receptor signaling. TIMER database indicated that the AlkB family had a strong relationship with the infiltration of six types of immune cells (macrophages, neutrophils, CD8+ T-cells, B-cells, CD4+ T-cells and dendritic cells). Next, DiseaseMeth databases revealed that the global methylation levels of ALKBH1/2/3/4/5/6/7/8 and FTO were all lower in OV patients. Thus, our findings will enhance the understanding of AlkB family in OV pathology, and provide novel insights into AlkB-targeted therapy for OV patients.
引用
收藏
页码:9679 / 9692
页数:14
相关论文
共 50 条
  • [21] Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
    Huimei Zhou
    Qian Liu
    Xiaohua Shi
    Yue Liu
    Dongyan Cao
    Jiaxin Yang
    Journal of Ovarian Research, 13
  • [22] Differential microma expression in primary peritoneal serous carcinoma versus ovarian serous
    O'Leary, J. J.
    Smyth, P.
    Laios, A.
    O'Toole, S.
    Russell, S.
    Li, J.
    Denning, K.
    Aherne, S.
    Ring, M.
    Martin, C.
    Sheppard, B.
    Lao, K.
    Sheils, O.
    Flavin, R. J.
    MODERN PATHOLOGY, 2008, 21 : 216A - 216A
  • [23] Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma
    Norris, Eric J.
    Zhang, Qing
    Jones, Wendell D.
    DeStephanis, Darla
    Sutker, Ashley P.
    Livasy, Chad A.
    Ganapathi, Ram N.
    Tait, David L.
    Ganapathi, Mahrukh K.
    JOURNAL OF PATHOLOGY, 2019, 248 (03): : 352 - 362
  • [24] Expression profiles in matched primary and recurrent serous ovarian carcinomas.
    Zajchowski, D. A.
    Karlan, B. Y.
    Shawver, L. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium
    Qiu, Chunping
    Lu, Nan
    Wang, Xiao
    Zhang, Qing
    Yuan, Cunzhong
    Yan, Shi
    Dongol, Samina
    Li, Yingwei
    Sun, Xiaomei
    Sun, Chenggong
    Zhang, Zhiwei
    Zheng, Wenxin
    Kong, Beihua
    GYNECOLOGIC ONCOLOGY, 2017, 147 (03) : 634 - 641
  • [26] Integrated Analysis of Gene Expression and Tumor Nuclear Image Profiles Associated with Chemotherapy Response in Serous Ovarian Carcinoma
    Liu, Yuexin
    Sun, Yan
    Broaddus, Russell
    Liu, Jinsong
    Sood, Anil K.
    Shmulevich, Ilya
    Zhang, Wei
    PLOS ONE, 2012, 7 (05):
  • [27] Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma
    Jazaeri, AA
    Lu, K
    Schmandt, R
    Harris, CP
    Rao, PH
    Sotiriou, C
    Chandramouli, GVR
    Gershenson, DM
    Liu, ET
    MOLECULAR CARCINOGENESIS, 2003, 36 (02) : 53 - 59
  • [28] Molecular Management of High-Grade Serous Ovarian Carcinoma
    Punzon-Jimenez, Paula
    Lago, Victor
    Domingo, Santiago
    Simon, Carlos
    Mas, Aymara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [29] Expression of octamer-4 in serous and mucinous ovarian carcinoma
    Zhang, Jing
    Li, Yan-Li
    Zhou, Cai-Yun
    Hu, Yu-Ting
    Chen, Huai-Zeng
    JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (10) : 879 - 883
  • [30] Expression of Nestin and CD133 in serous ovarian carcinoma
    Onisim, Andrea
    Iancu, Mihaela
    Vlad, Catalin
    Kubelac, Paul
    Fetica, Bogdan
    Fulop, Annamaria
    Achimas-Cadariu, Andrei
    Achimas-Cadariu, Patriciu
    JOURNAL OF BUON, 2016, 21 (05): : 1168 - 1175